CHZHF yields 37.04% · JNJ yields 2.13%● Live data
📍 CHZHF pulled ahead of the other in Year 1
Combined, CHZHF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CHZHF + JNJ for your $10,000?
China Zhongwang Holdings Limited, through its subsidiaries, develops, manufactures, and sells aluminium extruded products in the People's Republic of China, South Korea, Germany, the United States, and internationally. It operates through Aluminium Alloy Formworks, Industrial, Construction, Flat-Rolled, Further Fabricated, Leasing, and Others segments. The company offers high precision, large-section, and value-added industrial aluminum extrusion products for use in ecological construction, transportation, machinery and equipment, and electric power engineering sectors; and aluminum flat rolled products. It is also involved in the manufacture of machinery, and special vehicle and parts; trading of aluminum ingots, rods, and other materials; and manufacture of aluminum extrusion molds, alloy construction formworks, vehicle compartments, furniture, and vessels, as well as provision of investment consulting services. The company was founded in 1993 and is headquartered in Liaoyang, the People's Republic of China. China Zhongwang Holdings Limited is a subsidiary of Zhongwang International Group Limited.
Full CHZHF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.